Califf Defends Against Proposed Cuts to FDA’s Budget for Fiscal 2024

If the FDA is forced to go back to fiscal 2022 levels — as House Republicans are proposing — there will be fewer inspections, new drug products won’t get approved and drug companies will flock to other countries, said FDA Commissioner Robert Califf during a fiscal 2024 budget hearing on Wednesday.
Source: Drug Industry Daily